Latest Posts
About This Stock
More About This Stock
Read
Read
Read
Week In Review: Agilent Pays $250 Million To Acquire ACEA And Its Cell Therapy Analyzer
Article By:
ChinaBio® Today
Saturday, September 29, 2018 4:11 PM EDT
ACEA Biosciences, a San Diego company with R&D and manufacturing facilities in Hangzhzou, will be acquired by Agilent for $250 million in cash. ACEA developed the xCELLigence® cell therapy analysis device used by academic and biopharma researchers.
Week In Review: Mevion Medical Of Boston Closes $150 Million Financing From China Investors
Article By:
ChinaBio® Today
Saturday, June 16, 2018 4:07 PM EDT
Mevion Medical Systems, a Boston area maker of proton therapy machines, closed a $150 million financing led by YuanMing Capital with participation by other China-based private equity investors.
Week In Review: Taiwan Liposome Files For $50 Million Secondary IPO In The US
Article By:
ChinaBio® Today
Saturday, February 24, 2018 5:33 PM EDT
Taiwan Liposome (TW: 4152), a company developing extended-release delivery of known drugs, filed for a $50 million IPO on the NASDAQ exchange (see story). The company is listed in Taiwan, where it has a market capitalization of $198 million.
In this article: TTPH